21 CFR 870.5550
§ 870.5550 External transcutaneous cardiac pacemaker (noninvasive).
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 870.5550, § 870.5550 External transcutaneous cardiac pacemaker (noninvasive), United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90030
- Permanent ID
ys:prov:90030@1- SHA-256
fcc0e718b0255f7becd0a21cbe541add8a92ade734f55af704592abd715a960b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. An external transcutaneous cardiac pacemaker (noninvasive) is a device used to supply a periodic electrical pulse intended to pace the heart. The pulse from the device is usually applied to the surface of the chest through electrodes such as defibrillator paddles.
(b) Classification. Class II. The special controls for this device are:
(1) “American National Standards Institute/American Association for Medical Instrumentation's DF-21 ‘Cardiac Defibrillator Devices’ ” 2d ed., 1996, and
(2) “The maximum pulse amplitude should not exceed 200 milliamperes. The maximum pulse duration should not exceed 50 milliseconds.”
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.